BACTERIAL STI / CARE & TRANSMISSION
Chlamydia trachomatis
Chlamydia often causes no symptoms and is usually cured with antibiotics. It can affect genital or rectal tissue and sometimes the throat. Testing the sites that match the contact, treating a confirmed infection, and a retest a few months later cover most of what matters. [13]
Transmission risk
Risk by type of contact
Bottom line. Chlamydia can transmit through vaginal, anal and oral contact without symptoms. Condoms reduce risk, but available partnership models and clinic studies cannot yield a single trustworthy protected-act percentage.
General
Oral
Vaginal
Anal
Kissing
What changes the risk (3)
- Doxy-PEP. HIGH for studied populations: CDC 2024 summarizes greater than 70% relative reductions in chlamydia incidence in randomized trials; not a per-act estimate. Evidence mainly concerns MSM and transgender women, not all populations. Sources 6
- Treatment / reinfection. LOW for numerical prevention effect: successful treatment removes the current infection, but untreated partners and subsequent contacts can cause reinfection; no durable immunity assumed. Sources 1
- Ejaculation, menstruation, circumcision and concurrent STIs. LOW: no reliable generalizable route-specific multiplier identified. Do not treat absence of ejaculation as no exposure. Sources 1, 3
Condoms and dental dams
A retrospective study of known exposed contacts found 13.3% positivity with consistent versus 34.4% with inconsistent use; adjusted OR 0.10 (95% CI 0.01-0.83). These are positivity and odds outcomes, not a perfect-use per-act trial. Evidence: Medium Sources 2
Sources for this risk profile (6)
- CDC CDC, 2021. Chlamydial Infections - STI Treatment Guidelines. cdc.gov
- Niccolai LM, Rowhani-Rahbar A, Jenkins H, Green S, Dunne DW Sexually Transmitted Infections, 2005. Condom effectiveness for prevention of Chlamydia trachomatis infection. DOI: 10.1136/sti.2004.012799. pubmed.ncbi.nlm.nih.gov
- CDC CDC, 2024. About STI Risk and Oral Sex. cdc.gov
- Lewis J, White PJ, Price MJ International Journal of Epidemiology, 2021. Per-partnership transmission probabilities for Chlamydia trachomatis infection: evidence synthesis of population-based survey data. DOI: 10.1093/ije/dyaa202. academic.oup.com
- Charleson F et al. Sexually Transmitted Diseases, 2023. A systematic review of kissing as a risk factor for oropharyngeal gonorrhea or chlamydia. DOI: 10.1097/OLQ.0000000000001777. research.monash.edu
- Bachmann LH et al.; CDC MMWR Recommendations and Reports, 2024. CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024. DOI: 10.15585/mmwr.rr7302a1. cdc.gov
* How to read these figures. Each is a published estimate under the conditions shown beside it, usually an untreated partner and a single act or partnership. It is not a prediction of your personal risk.
- Evidence: High
- Several prospective studies or a systematic review broadly agree.
- Evidence: Medium
- One or two studies, wide uncertainty, or a model.
- Evidence: Low
- Guideline judgment, case reports, or extrapolation.
Where no risk level is shown, the evidence cannot rank it. That is not the same as low.
Evidence reviewed through 2026-10-27. For reference only; not medical advice.
When to test after a possible exposure
If you decide to test, about 14 days after a contact is a practical first point. Symptoms, or contact with someone who has a confirmed result, are reasons to talk to a clinic sooner.
When to be seen sooner. Symptoms or a partner diagnosis warrant prompt evaluation.
-
Chlamydia NAAT
About 2 weeks is a common public-service testing interval, not a proven first-detectable day or a universal 100% sensitivity threshold.
Symptoms or a confirmed contact are reasons to be seen sooner; if an early result is negative, the clinic may suggest a repeat around its usual interval.
Specimens: First-pass urine for urethral infection; Vaginal swab; Rectal swab when relevant; Throat specimen where clinically indicated / locally recommended
Sources 1, 2
Early negatives, after treatment, and screening limits
An early negative result. An early negative or an unsampled site does not exclude infection there. Repeat according to exposure timing and the clinical plan; a new exposure creates a new timing question.
After treatment. CDC: avoid NAAT-based test of cure before 4 weeks after completion because nonviable organisms can remain detectable. Routine test of cure is not advised for most nonpregnant treated people; pregnancy and selected concerns differ. Retesting around 3 months looks for reinfection, not the original window.
Screening limits. Screening depends on age, anatomy, practices and local guidance. A testing window does not justify delaying treatment of a known contact when presumptive treatment is indicated.
Kissing and body sites. Genital testing does not cover the throat or rectum. Throat chlamydia screening is not universally recommended and is often obtained through combined chlamydia/gonorrhea assays; do not order every-site testing after every kiss.
Sources for testing guidance (2)
- NHS inform, Scotland. STI testing at home. Live guidance. nhsinform.scot
- CDC STI Treatment Guidelines. Chlamydial Infections: diagnosis and follow-up. 2021. cdc.gov
Treatment
Doxycycline for seven days is a common first-line adult regimen and is preferred for rectal infection. Pregnancy, contraindications and adherence can change the prescription. Do not share leftover antibiotics. Complicated infection, including pelvic inflammatory disease or lymphogranuloma venereum, requires a different assessment and sometimes a longer course. [13]
Actions
1. Choose specimens by exposure. Ask for genital testing and a rectal swab after relevant anal exposure. Pharyngeal chlamydia screening is not routinely recommended by CDC, although combined throat tests obtained for gonorrhea may detect it. [13][61]
2. Tell recent partners. Partners who had direct sexual contact within the lookback period can be offered testing or treatment. US CDC guidance uses the 60 days before symptoms or diagnosis, plus the most recent partner even if earlier; Australian guidance uses six months. The local clinic's window applies, and someone who only shares a partner is not a direct contact. [13][14]
3. Pause, then retest. Wait to have sex until the seven-day course is finished, symptoms have settled and partners have been treated; after single-dose treatment, wait seven days. A retest at about three months checks for reinfection. In pregnancy, a test of cure around four weeks is usual; testing much earlier can mislead. [13]
SCIENCE & CONTEXT
Chlamydia / the evidence
History
The organism responsible for ocular trachoma was successfully cultivated in embryonated eggs in the 1950s, helping establish chlamydiae as bacteria rather than viruses. Ocular and genital disease are distinct clinical manifestations of related strains. Modern NAATs replaced less-sensitive detection methods and made self-collected specimens practical in many settings. [13][15]
Impact
C. trachomatis grows inside cells. Genital infection can inflame the cervix or urethra; rectal infection may cause pain, bleeding or discharge, and many infections cause no symptoms. Untreated infection can sometimes move upward and cause pelvic inflammatory disease, which can affect the fallopian tubes, or epididymitis. Treating it early prevents this; treatment cannot always reverse scarring that has already formed. [13]
A repeat positive test may represent reinfection, testing too soon after treatment, or less often treatment failure. Partner treatment and a three-month retest address a common practical problem: acquisition again after the original infection was cured. [13]
Probability at a glance
Chance that at least one recent partner has genital chlamydia, by number of partners in six months, using one club study. This is not your chance of getting it.
| Partners | 1.7% genital scenario |
|---|---|
1-2 | 1.7–3.4 |
3-5 | 5.0–8.2 |
6-10 | 9.8–15.8 |
11-20 | 17.2–29.0 |
One direct club study found 1.7% genital chlamydia positivity in 235 participants. The table applies that one benchmark to independent partners; it is not a universal or upper-end prevalence estimate. [04]
In short: the risk from one act is low, but it adds up with repeated contact, and a genital-only test does not cover rectal infection.